跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BEATACYCLINE CAPSULE 250 MG - NPRA Drug Approval Details
Approvals
/
NPRA
/
BEATACYCLINE CAPSULE 250 MG
Approved
STANDARD
BEATACYCLINE CAPSULE 250 MG
DUOPHARMA MANUFACTURING (BANGI) SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 28, 2025
Approval ID
46b7ae3e6385be52
Company
DUOPHARMA MANUFACTURING (BANGI) SDN. BHD.
Type
Standard
Approval Details
Approval Id
46b7ae3e6385be52
Drug Approval Npra Name
BEATACYCLINE CAPSULE 250 MG
Product Name
BEATACYCLINE CAPSULE 250 MG
Registration Number
MAL19860247AZ
Holder Company Name
DUOPHARMA MANUFACTURING (BANGI) SDN. BHD.
Holder Address
LOT NO. 2, 4, 6, 8 & 10, JALAN P/7 SECTION 13, BANGI INDUSTRIAL ESTATE 43650 BANDAR BARU BANGI MALAYSIA
Holder Phone
03-89242188
Manufacturer Company Name
DUOPHARMA MANUFACTURING (BANGI) SDN. BHD.
Manufacturer Address
LOT NO. 2 & 4, JALAN P/7 SECTION 13, BANGI INDUSTRIAL ESTATE 43650 BANDAR BARU BANGI MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL19860247AZ
Version
1751614167
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 28, 2025
Approval ID
46b7ae3e6385be52
Type
Standard
Source
Official Source
Back to NPRA Approvals